Randall Dere

机构：Amgen (United States), Bioanalytica (Switzerland), Mahindra and Mahindra Limited (India) · ORCID：0000-0003-4120-7828

发表论文 52 篇 · 总被引 1680 次 · h-index 18

代表论文

Proteomics approach identifies aqueous humor biomarkers in retinal diseases (2025 · Communications Medicine · 被引 13)
Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study (2024 · CPT Pharmacometrics & Systems Pharmacology · 被引 7)
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration (2025 · American Journal of Ophthalmology · 被引 6)
Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX (2023 · Clinical and Translational Science · 被引 6)
Clinical pharmacology strategies to accelerate the development of polatuzumab vedotin and summary of key findings (2024 · Advanced Drug Delivery Reviews · 被引 5)
A novel biomarker assay qualification strategy for rare human matrices – a case study of biomarkers in aqueous humor (2024 · Bioanalysis · 被引 2)